Cargando…
Metoprolol Improves Endothelial Function in Patients with Cardiac Syndrome X
Endothelial dysfunction which is manifested by the loss of nitric oxide bioavailability, is an increasingly recognized cause of cardiac syndrome X (CSX) and beta blockers are used for the treatment of this syndrome. Thus, the aim of this study was to investigate effects of metoprolol, as a beta bloc...
Autores principales: | Majidinia, Maryam, Rasmi, Yousef, Khadem Ansari, Mohammad Hassan, Seyed-Mohammadzad, MirHossein, Saboory, Ehsan, Shirpoor, Alireza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shaheed Beheshti University of Medical Sciences
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5149044/ https://www.ncbi.nlm.nih.gov/pubmed/27980592 |
Ejemplares similares
-
Increased circulating platelet and endothelial-derived microparticles in patients with cardiac syndrome X
por: Ghaffari, Fereshteh, et al.
Publicado: (2021) -
Association of endothelial dysfunction and cytotoxin-associated gene A-positive Helicobacter pylori in patients with cardiac syndrome X
por: Rasmi, Yousef, et al.
Publicado: (2016) -
Increased levels of angiogenic factors in microvascular angina
por: Asl, Elmira Roshani, et al.
Publicado: (2019) -
Transcriptional activity of tumor necrosis factor-alpha gene in peripheral blood mononuclear cells in patients with coronary slow flow
por: Rasmi, Yousef, et al.
Publicado: (2017) -
Transcriptional Activity of Gene Encoding Subunits R1 and R2 of Interferon Gamma Receptor in Peripheral Blood Mononuclear Cells in Patients with Slow Coronary Flow
por: Faramarz-Gaznagh, Sanaz, et al.
Publicado: (2016)